From the courtrooms of Nuremberg to the battlefields of the Gulf War, Undue Risk exposes a variety of government policies and specific cases, includingplutonium injections to unwilling hospital patients, and even the attempted recruitment of Nazi medical scientists bythe U.S. government after World War II.

An eye-opening look at the inevitable moral choices that come along with tremendous medical progress, Everybody Wants to Go to Heaven but Nobody Wants to Die is a primer for all Americans to talk more honestly about health care. Beginning in the 1950s when doctors still paid house calls but regularly withheld the truth from their patients, Amy Gutmann and Jonathan D. Moreno explore an unprecedented revolution in health care and explain the problem with Americans wanting everything that medical science has to offer without debating its merits and its limits. The result: Americans today pay far more for health care while having amongst the lowest life expectancies and highest infant mortality of any affluent nation. Gutmann and Moreno-"incisive, influential, and pragmatic thinkers" (Arthur Caplan)-demonstrate that the stakes have never been higher for prolonging and improving life. From health care reform and death-with-dignity to child vaccinations and gene editing, they explain how bioethics came to dominate the national spotlight, leading and responding to a revolution in doctor-patient relations, a burgeoning world of organ transplants and new reproductive technologies that benefit millions but create a host of legal and ethical challenges. With striking examples, the authors show how breakthroughs in cancer research, infectious disease and drug development provide Americans with exciting new alternatives, yet often painful choices. They address head-on the most fundamental challenges in American health care: Why do we pay so much for health care while still lacking universal coverage? How can medical studies adequately protect individuals who volunteer for them? What's fair when it comes to allocating organs for transplants in truly life-and-death situations? A lucid and provocative blend of history and public policy, this urgent work exposes the American paradox of wanting to have it all without paying the price.

Undue Risk is an unprecedented and chilling history of the use of human subjects in atomic, biological and chemical warfare experiments by the US Government from World War II to the present. Jonathan Moreno, a senior researcher on the President's special commission, goes where few researchers have gone before, exploring secret government documents which reveal a plethora of government experiments.
Now available in paperback, with a new afterword, this exciting read covers recent objections by US military personnel to required anthrax vaccinations and new developments in government policies on experiments involving vulnerable human subjects.

All investigators funded by the National Institutes of Health are now required to receive training about the ethics of clinical research. Based on a course taught by the editors at NIH, Ethical and Regulatory Aspects of Clinical Research is the first book designed to help investigators meet this new requirement. The book begins with the history of human subjects research and guidelines instituted since World War II. It then covers various stages and components of the clinical trial process: designing the trial, recruiting participants, ensuring informed consent, studying special populations, and conducting international research. Concluding chapters address conflicts of interest, scientific misconduct, and challenges to the IRB system. The appendix provides sample informed consent forms.

This book will be used in undergraduate courses on research ethics and in schools of medicine and public health by students who are or will be carrying out clinical research. Professionals in need of such training and bioethicists also will be interested.

The UNESCO International Bioethics Committee is an international body that sets standards in the field of bioethics. This collection represents the contributions of the IBC to global bioethics. The IBC is a body of 36 independent experts that follows progress in the life sciences and its applications in order to ensure respect for human dignity and freedom. Currently, some of the topics of the IBC contributions have been discussed in the bioethics literature, mostly journal articles. However, this is a unique contribution by the scholars who developed these universal declarations and reports. The contributors have not only provided a scholarly up to date discussion of their research topics, but as members of the IBC they have also discussed specific practical challenges in the development of such international documents. This book will be suited to academics within bioethics, health care policy and international law.

The UNESCO International Bioethics Committee is an international body that sets standards in the field of bioethics. This collection represents the contributions of the IBC to global bioethics. The IBC is a body of 36 independent experts that follows progress in the life sciences and its applications in order to ensure respect for human dignity and freedom. Currently, some of the topics of the IBC contributions have been discussed in the bioethics literature, mostly journal articles. However, this is a unique contribution by the scholars who developed these universal declarations and reports. The contributors have not only provided a scholarly up to date discussion of their research topics, but as members of the IBC they have also discussed specific practical challenges in the development of such international documents. This book will be suited to academics within bioethics, health care policy and international law.

The human brain is the most complex object in the known universe. The field of neuroscience has made remarkable strides in recent years in understanding aspects of the brain, yet we still struggle with seemingly fundamental questions about how the brain works. What lessons can we learn from neuroscience's successes and failures? What kinds of questions can neuroscience answer, and what will remain out of reach? In The Brain in Context, the bioethicist Jonathan D. Moreno and the neuroscientist Jay Schulkin provide an accessible and thought-provoking account of the evolution of neuroscience and the neuroscience of evolution. They emphasize that the brain is not an isolated organ-it extends into every part of the body and every aspect of human life. Understanding the brain requires studying the environmental, biological, chemical, genetic, and social factors that continue to shape it. Moreno and Schulkin describe today's transformative devices, theories, and methods, including technologies like fMRI and optogenetics as well as massive whole-brain activity maps and the attempt to create a digital simulation of the brain. They show how theorizing about the brain and experimenting with it often go hand in hand, and they raise cautions about unintended consequences of technological interventions. The Brain in Context is a stimulating and even-handed assessment of the scope and limits of what we know about how we think.

An eye-opening look at the inevitable moral choices that come along with tremendous medical progress, Everybody Wants to Go to Heaven but Nobody Wants to Die is a primer for all Americans to talk more honestly about health care. Beginning in the 1950s when doctors still paid house calls but regularly withheld the truth from their patients, Amy Gutmann and Jonathan D. Moreno explore an unprecedented revolution in health care and explain the problem with Americans wanting everything that medical science has to offer without debating its merits and its limits. The result: Americans today pay far more for health care while having amongst the lowest life expectancies and highest infant mortality of any affluent nation. Gutmann and Moreno-"incisive, influential, and pragmatic thinkers" (Arthur Caplan)-demonstrate that the stakes have never been higher for prolonging and improving life. From health care reform and death-with-dignity to child vaccinations and gene editing, they explain how bioethics came to dominate the national spotlight, leading and responding to a revolution in doctor-patient relations, a burgeoning world of organ transplants and new reproductive technologies that benefit millions but create a host of legal and ethical challenges. With striking examples, the authors show how breakthroughs in cancer research, infectious disease and drug development provide Americans with exciting new alternatives, yet often painful choices. They address head-on the most fundamental challenges in American health care: Why do we pay so much for health care while still lacking universal coverage? How can medical studies adequately protect individuals who volunteer for them? What's fair when it comes to allocating organs for transplants in truly life-and-death situations? A lucid and provocative blend of history and public policy, this urgent work exposes the American paradox of wanting to have it all without paying the price.

A "Kirkus Reviews" Best Book of the Year and "Scientific American" Book Club selection

"Moreno pulls apart the debates on eugenics, abortion, end-of-life decisions, embryonic stem-cell research, reproductive cloning, chimeras and synthetic biology, among others, carefully reassembling what's at stake for each side. In graceful, sparkling prose, he illuminates intricate threads of history and complex philosophical arguments. . . . Highly recommended for anyone interested in the se] vital issues." --"Kirkus Reviews" (starred review)

We have entered what is called the "biological century" and a new biopolitics has emerged to address the implications for America's collective value system, our well-being, and ultimately, our future. "The Body Politic" is the first book to recognize and assess this new force in our political landscape--one that fuels today's culture wars and has motivated politicians of all stripes to reexamine their platforms. As Moreno explains the most contentious issues, he also offers an engaging history of the intersection between science and democracy in American life, a reasoned (and often surprising) analysis of how different political ideologies view scientific controversies, and a vision for how the new biopolitics can help shape the quality of our lives.

Jonathan D. Moreno is the David and Lyn Silfen University Professor at the University of Pennsylvania and the editor-in-chief for the Center for American Progress' online magazine, "Science Progress." He divides his time between Philadelphia and Washington, DC.

The proliferation of life-prolonging technology in recent years has made the controversy over the "right to die" and physician-assisted suicide one of the most explosive medical and ethical issues of our day. Dr. Jack Kevorkian's "suicide machine" has commanded front-page coverage for several years, while in 1994 Oregon passed a measure allowing the terminally ill to obtain lethal prescriptions for suicide, and other states have placed similar proposals on their ballots.

Arguing Euthanasia brings together for the first time an impressive array of viewpoints from both sides of this emotionally charged question as well as voices from the gravely ill and their loved ones. Beginning with a selection of pieces from the New England Journal of Medicine, where the debate was ignited in 1988, Arguing Euthanasia features essays by such outspoken advocates of active euthanasia as Timothy Quill and Sidney Hook, and important social critics and commentators such as Nat Hentoff, Leon R. Kass, and Ronald Dworkin.

As they probe the legal and ethical issues at the heart of physician-assisted suicide, these essays offer invaluable insights not only for those caring for the terminally ill but for anyone concerned with the deeper philosophical conflict between enduring life-oriented values and personal dignity that lies at the heart of this controversy.

Ethics in Clinical Practice, Second Edition continues to focus on multidisciplinary medicine and how ethical dilemmas affect not only doctors and patients, but also nurses, social workers, members of ethics committees, hospital attorneys, administrators, and others. Greater attention is given to care in a variety of settings and across settings. Cases reflect the managed care phenomenon and cost containment, demographic changes, the electronic revolution, and the ethical dilemmas resulting from this new climate. The revised edition discusses advances in palliative medicine and its availability, and includes new data regarding attitudes and prevalence of physician-assisted suicide. Attention is given to how issues of cost containment might directly or indirectly influence patients' end-of-life treatment options. Cases are updated to include pertinent information about medical advances and legal developments, and how ethical analysis reflects these new developments.

Although it does not seem unusual to us that professionals be compensated for the product or service they provide, there are some professions that make us feel uncomfortable with the necessity of payment. "Paying the Doctor" explores this dilemma as it relates to the health care field. It analyzes and explains the roles of the health care provider, patient, and market influences in cost and reimbursement. Part introductions to each section familiarize the reader with the specific concerns it contains, and an overall conclusion describes the major points of a planned future payment system.

The goal of this volume was to create a book that was general enough to serve as an introduction for members of the health care field and sophisticated enough to appeal also to researchers. To achieve this, editor Jonathan Moreno enlists the aid of a diverse group of professionals: health care providers, economists, historians, philosophers, and others. They begin by providing a series of studies that describe and apply various frameworks for analyzing physician payment, the first of which shows exactly what an enormous challenge the entire subject of reimbursement poses. The following section studies various payment mechanisms. Successive sections study specific professional groups and the Medicare system. Based on this information, a new payment system expected to be introduced within a few years is discussed.